ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

ACS Announces New Awards for Nurses

October 30, 1987

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

OHSU Get $500 Million Pledge; Funds to be Matched in Two Years

September 27, 2013

FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says.

March 4, 2005